Table 1.
Controls | PD-FOG | PD+FOG | P | |
---|---|---|---|---|
N (female) | 24 (19) | 24 (14) | 20 (7) | - |
Age | 66.04±7.30 | 68.79±6.92 | 67.10±8.28 | 0.44 |
MMSE, median (range) | 29 (25, 30) | 28 (26, 30) | 29 (26, 30) | 0.18 |
Fallers | 6 | 9 | 16 | - |
Yrs since dx | - | 6.04±3.44 | 8.65±5.77 | 0.07 |
LEDD | - | 777 ± 476 (22) | 1,307 ±1,032 (18) | 0.06 |
UPDRS III | - | 24.04±8.68 | 27.55±15.09 | 0.34 |
H&Y, median (range) | - | 2 (2, 2) | 2 (2, 3) | 0.12 |
N-FOGQ | - | 0.00±0.00 | 16.85±8.24 | - |
Values are mean ± SD unless noted. Fallers defined as participants who experienced one or more falls in the past 6 months. T-tests and ANOVAs used for between group comparisons as appropriate. Abbreviations: Hoehn and Yahr, H&Y; Levodopa-Equivalent Daily Dose, LEDD; Mini Mental State Examination, MMSE; Movement Disorders Society Unified Parkinson Disease Rating Scale Part 3, MDS-UPDRS-III; N-FOGQ, New Freezing of Gait Questionnaire.